Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb
What this study shows
TSC1-TSC2 acts as a GTPase-activating protein (GAP) for Rheb; when TSC is inactive, Rheb accumulates in its active GTP-bound form and directly activates mTORC1.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human cell lines) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human cell lines |
| Journal | Current Biology |
| Year | 2003 |
| Peer reviewed | Yes |
| Record last updated | 2026-08-22 |
| Source | DOI 10.1016/s0960-9822(03)00506-2 · PMID 12906785 |
Extracted findings
| Intervention | Biochemical/genetic (TSC1/TSC2) |
| Target | TSC1-TSC2 (Hamartin/Tuberin) / Rheb / mTOR |
| Model | Human cell lines |
| Effect | Tuberin-Hamartin (TSC1-TSC2) control mTOR by acting as a GAP complex toward Rheb |
In the Atlas
Related topics
More studies on this topic
- Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 (2003)
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling (2003)
- Rheb binds and regulates the mTOR kinase (2005)
- PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (2007)
Learn the biology
Want to understand the biology behind this study? → The TSC Complex — Where the Inputs Meet